Searchable abstracts of presentations at key conferences in endocrinology

ea0028p351 | Thyroid | SFEBES2012

TBII at discontinuation of ATD therapy as a predictor of relapse of hyperthyroidism in Graves’ disease - a prospective analysis

Stewart Kathryn , Handley Graham , Razvi Salman

Background: Graves’ hyperthyroidism is treated with anti-thyroid drugs (ATD) for 12–18 months, after which ~50% of patients remain euthyroid. Risk factors predicting relapse are: male gender, younger age, orbitopathy, large goitres, severe hyperthyroidism at diagnosis and smoking. Recent reports suggest measurement of TBII at ATD cessation is useful in predicting risk of relapse. Aim: To prospectively investigate whether TBII levels at cessation of ATD therapy are us...

ea0025p38 | Clinical biochemistry | SFEBES2011

Hypocalcaemia presenting via an acute medical admissions unit is only rarely adequately investigated

Griffiths Rebecca , Pattman Stewart , Quinton Richard

Aim: To determine whether cases of hypocalcaemia presenting via an emergency medical admissions unit (EAU) are appropriately investigated.Background: Hypocalcaemia is a potentially life threatening abnormality, with a prevalence of 18% among hospital inpatients.1,2 Risk factors include vitamin D deficiency, renal disease, hypoparathyroidism (typically post-neck surgery) and hypomagnesaemia. A reasonable investigational dataset comprises U+Es a...

ea0021p126 | Cytokines and growth factors | SFEBES2009

Differential effects of eicosapentaenoic acid (EPA) and palmitate on tumour necrosis factor (TNF-α) and insulin-like growth factor (IGF1) action in murine skeletal muscle cells

Saini Amarjit , Al-Shanti Nasser , Stewart Claire

Introduction: Sarcopenic obesity prevails with ageing, encompassing excess weight gains and muscle mass or strength losses. Free fatty acids and proinflammatory cytokines are elevated in obese adults. Palmitate decreases the anabolic effects of IGF signalling, while EPA elicits anti-inflammatory activities.We aimed to examine the effects of palmitate and EPA on TNF-α/IGF1 interactions in established models of skeletal muscle cell loss.<p class="...

ea0021p127 | Cytokines and growth factors | SFEBES2009

Atrophy or hypertrophy: differential responses of C2 and C2C12 mouse skeletal myoblasts in the absence or presence of tumour necrosis factor-α (TNF-α)

Sharples Adam , Al-Shanti Nasser , Stewart Claire

Inflamed ageing is associated with reduced muscle mass and increased susceptibility to TNF-induced muscle protein degradation. We therefore aimed to elucidate mechanisms supporting reduced hypertrophy and increased atrophy of skeletal myoblasts. C2 myoblasts display diminished differentiation and increased susceptibility to TNF-α-induced apoptosis versus daughter C2C12 cells, providing us with relevant models. C2 and C2</su...

ea0021p236 | Neuroendocrinology and behaviour | SFEBES2009

The endocrine and behavioural effects of high fat feeding

McNeilly Alison , Balfour David , Stewart Caroline

Diet induced obesity is associated with an increased relative risk of developing type 2 diabetes, hypertension, dyslipidemia and cardiovascular complications. In addition to these co-morbidity factors there is increasing evidence to suggest that obese insulin resistant individuals show impaired negative feedback control of the HPA axis in response to stress. Here we investigate HPA axis response to an acute stress following high fat feeding in rats.Male ...

ea0019p98 | Clinical practice/governance and case reports | SFEBES2009

Endocrine genes – have we improved the fit? (project development to service provision)

Stewart S , Gittoes N , Cole T

In 2006, responding to the Government White Paper, ‘Our future, our inheritance’, a project commenced promoting genetics in mainstream medicine.By 2008, the original project framework has evolved to address logistical constraints, patient preference and cost effectiveness, offering a streamlined service for clients with inherited endocrine disorders. Recognised patient pathways and a dedicated endocrine genetic clinical nurse specialist (EGCNS)...

ea0014p356 | (1) | ECE2007

Outcomes of a fixed dose of 370 MBq of radioiodine in hyperthyroidism

Howat Isabel , Sawers Hilary , Sawers Stewart

In 1995 the Royal College of Physicians issued guidelines for the use of radioiodine in hyperthyroidism. They recommended administration of enough radioiodine to achieve euthyroidism, with acceptance of a moderate rate of hypothyroidism e.g. 15–20% at 2 years and 1–3% per annum thereafter. Guide activity was 400–550 MBq for standard hyperthyroidism (mainly Graves’ disease), at least 550 MBq for toxic multinodular goitre, and 300–500 MBq in toxic adenom...

ea0013p123 | Cytokines and growth factors | SFEBES2007

Controversial interactions between TNF-alpha and IL-6 in C2 skeletal myoblast cell death

Al-Shanti Nasser , Saini Amarjit , Stewart Claire

Introduction: The role of TNF-alpha in muscle wasting diseases if a topic of great interest. However, the role of interleukin-6 (IL-6) in some pathological diseases and in skeletal muscle is controversial. Physical exercise provides protection against several human diseases, e.g. cardiovascular disease, heart failure and claudicatio intermittens. This protection is associated with the muscle specific production of IL-6. In contrast to its protective role during exercise, eleva...

ea0011oc28 | Diabetes and metabolism | ECE2006

11β-Hydroxysteroid dehydrogenase type 1 oxo-reductase activity is increased in patients with alcoholic chronic liver disease: the key to the phenotype of the alcoholic pseudo-Cushing’s state?

Ahmed A , Saksena S , Elias E , Stewart PM

The pseudo-Cushing’s syndrome that accompanies both acute alcohol ingestion and alcohol withdrawal is an important differential diagnosis of hypercortisolism that is poorly understood. Two isozymes of 11β-hydroxysteroid dehydrogenase (11β-HSD) interconvert hormonally active cortisol (F) and inactive cortisone (E). Previously we have shown higher urinary F:E metabolite ratios (a reflection of total body 11βHSD activity) in patients with alcoholic liver disea...

ea0011p334 | Diabetes, metabolism and cardiovascular | ECE2006

Regulation of hexose-6-phosphate dehydrogenase (H6PDH) in human fetal liver WRL-68 cells

Swali A , Bujalska I , Stewart PM , Walker EA

Excessive glucocorticoid exposure has been implicated in the pathogenesis of obesity and the metabolic syndrome. The in vivo conversion of inactive to active glucocorticoids is catalysed by 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1), requiring NADPH as a cofactor. Hexose-6-phosphate dehydrogenase (H6PDH) is co-localised with 11β-HSD1 in the lumen of the endoplasmic reticulum and controls local NADPH availability. Thus H6PDH plays an important role...